Clinical trial: Effects of pegozafermin on the liver and on metabolic comorbidities in subjects with biopsy-confirmed nonalcoholic steatohepatitis.
Rohit L LoombaDonald LazasRohit LoombaJuan P FriasShibao FengLeo TsengKemal BalicGermaine D AgollahTinna KwanJanani S IyerLinda MorrowHank MansbachMaya MargalitStephen A HarrisonPublished in: Alimentary pharmacology & therapeutics (2023)
gov: NCT04048135.